Strikingly, 18 sites of SUMOylation were detected from SUMO1, SUMO2 and SUMO3 themselves, all of which increased upon EBV reactivation (S1E Fig), suggesting increased SUMO polymerisation is a consequence of lytic EBV infection. The gene discussed is SUMO2; the disease is Epstein-Barr virus infection.